Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical ... - MarketWatch (press release)
Michael J.
Sunnyview Rehabilitation Hospital played role in newly published brain injury ... - Albany Business Review
Sunnyview Rehabilitation Hospital played role in newly published brain injury .
Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA ... - MarketWatch (press release)
Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA .
Newron Reports Completion of Phase III program for Safinamide in early and ... - PipelineReview.com (press release)
Newron Reports Completion of Phase III program for Safinamide in early and .
A 64-Year-Old Man With Motor Complications of Advanced Parkinson Disease - Journal of American Medical Association (subscription)
A 64-Year-Old Man With Motor Complications of Advanced Parkinson DiseaseJournal of American Medical Association (subscription)To treat his motor fluctuations medically, Mr L was asked to take his carbidopa-levodopa-entacapone dose every 3 hours instead of every 4 hours (a total of 5 doses daily), and 100 mg of amantadine twice daily was added to suppress his dyskinesias.